Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Somatrix Technologies is a biotechnology company specializing in regenerative medicine and advanced wound care solutions. The company develops proprietary extracellular matrix (ECM) technologies designed to facilitate tissue repair and regeneration in patients with chronic, non-healing wounds. Their lead platform mimics the natural biological scaffold of human tissue to promote cellular infiltration, vascularization, and organized collagen deposition. Somatrix primarily targets indications such as diabetic foot ulcers and pressure sores, aiming to improve clinical outcomes in complex dermatological cases. By leveraging bioactive scaffolds, the company provides clinicians with more effective tools for managing the wound microenvironment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Somatrix Technologies.